Teva

Teva 'disappointed' by Irish consultants' boycott of its pharmaceuticals, company tells 'Post'

Teva told the Post it remains committed to working constructively with healthcare professionals across Ireland and to supporting patients through the "consistent supply of high-quality medicines."

The logistics center of Teva Pharmaceutical Industries in Shoham
In January, Israel’s Ministry of Defense signed a multi-year contract with Semiconductor Devices valued at approximately $115 million (NIS 380 million).

The curse of being Israel's most valuable company

The logistics center of Teva Pharmaceutical Industries in Shoham

Mega deal: Teva acquires Emalex for approximately $900 million

Noam Zilbershtain, senior vice president and general manager, HP Indigo; Adi Soffer Teeni, CEO of Meta Israel, vice president and member of the EMEA leadership team; and Karin Mayer Rubinstein, CEO and president of IATI.

IATI CEOs Forum meets in Kiryat Gat to discuss multinational industry resilience


Digital innovation can help Israel deal with October 7 trauma. Here's how

Speaking at the Israel Summit, Dr. Eran Harary, a psychiatrist and a Senior Vice President at Teva's Global R&D, explained how Israelis can overcome the shock and find themselves more resilient.

 Dr. Eran Harary, a psychiatrist and a Senior Vice President at Teva's Global R&D

Teva to pay Nevada $193 million over role in opioid epidemic

Nevada, along with other states and thousands of local governments, accused Teva and other drugmakers of downplaying the addiction risks of opioid pain drugs.

 The logo of Teva Pharmaceutical Industries is seen in Tel Aviv, Israel February 19, 2019.

US Supreme Court rejects Teva challenge to $235 million GSK award in patent dispute

Israel's Teva Pharmaceuticals and GlaxoSmithKline (GSK) have been disputing over this patent lawsuit since 2014.

 Teva building in Kfar Saba

Israeli drugmaker Teva says opioids settlement to move forward in US

As a result of the opiod crisis, more than 932,000 people have died in the US since 1999 from a drug overdose.

 The logo of Teva Pharmaceutical Industries is seen in Tel Aviv, Israel February 19, 2019.

US Parkinson's disease incidence far higher than earlier estimates -study

Analysis of insurance claims and population growth indicates higher numbers than previously thought - and they will continue to rise.

 Parkinson's disease (illustrative)

NYSE gala honors Pfizer, Teva Pharmaceuticals, Silverstein Properties, Azrieli Group

Israel Day, organized and hosted by the America-Israel Friendship League and Israeli Mapped in NY annually holds the event in collaboration with the NY Stock Exchange to honor Israeli tech

 Pfizer, Teva Pharmaceuticals, Silverstein Properties and Azrieli Group Honored by the America Israel Friendship League (AIFL)  at its Annual Gala

Teva to pay $523m. to New York as it looks to move past opioid lawsuits

Teva Pharmaceutical Industries will pay up to $523 million to New York State as part of a nationwide settlement of lawsuits alleging the company helped fuel the US opioid epidemic.

 Teva building in Kfar Saba

Israel's Teva pharmaceuticals company keeps selling to Russia despite sanctions

Teva CEO Kare Schultz said that despite sanctions, Teva still sells medications to Russia, because this is a humanitarian move. He also revealed that Teva donates medicines to Ukraine.

 Teva building in Kfar Saba

Israel's Teva Pharm to start paying US opioid settlement in 2023, says CEO

The US opioid crisis has caused more than 500,000 overdose deaths over the past two decades, including more than 80,000 in 2021 alone.

 The CEO of Teva Pharmaceutical Industries Kare Schultz speaks during a news conference to discuss the company's 2019 outlooks in Tel Aviv, Israel February 19, 2019.

CVS, Walmart, Walgreens ordered to pay $650.6m. in Ohio in opioid case

The litigation has resulted in several nationwide settlements, including a $4.25 billion settlement with Israel-based Teva Pharmaceutical Industries

The steep rise in opioid use here is a real danger to public health